Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: what is missing?

Por Magdy, Tarek, Burmeister, Brian T., Burridge, Paul W.
Publicado no Pharmacol Ther (2016)

Human Stem Cells for Modeling Heart Disease and for Drug Discovery

Por Matsa, Elena, Burridge, Paul W., Wu, Joseph C.
Publicado em 2014

Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells

Por Burridge, Paul W., Holmström, Alexandra, Wu, Joseph C.
Publicado no Curr Protoc Hum Genet (2015)

Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine

Por Burridge, Paul W., Sharma, Arun, Wu, Joseph C.
Publicado no Annu Rev Genet (2015)

Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology

Por Gundry, Rebekah L., Burridge, Paul W., Boheler, Kenneth R.
Publicado em 2011

A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening and Publication Standards

Por Mordwinkin, Nicholas M., Burridge, Paul W., Wu, Joseph C.
Publicado em 2012

Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming

Por Burridge, Paul W., Keller, Gordon, Gold, Joseph D., Wu, Joseph C.
Publicado em 2012

Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation

Por Sharma, Arun, Li, Guang, Rajarajan, Kuppusamy, Hamaguchi, Ryoko, Burridge, Paul W., Wu, Sean M.
Publicado no J Vis Exp (2015)

Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes

Por Burridge, Paul W., Diecke, Sebastian, Matsa, Elena, Sharma, Arun, Wu, Haodi, Wu, Joseph C.
Publicado no Methods Mol Biol (2016)

Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model

Por Thompson, Susan A., Burridge, Paul W., Lipke, Elizabeth A., Shamblott, Michael, Zambidis, Elias T., Tung, Leslie
Publicado em 2012

Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells

Por PETERS, ANN, BURRIDGE, PAUL W., PRYZHKOVA, MARINA V., LEVINE, MICHAL A., PARK, TEA-SOON, ROXBURY, CHRISTOPHER, YUAN, XUAN, PÉAULT, BRUNO, ZAMBIDIS, ELIAS T.
Publicado em 2010

Doxorubicin induces caspase-mediated proteolysis of KV7.1

Por Strigli, Anne, Raab, Christian, Hessler, Sabine, Huth, Tobias, Schuldt, Adam J. T., Alzheimer, Christian, Friedrich, Thomas, Burridge, Paul W., Luedde, Mark, Schwake, Michael
Publicado no Commun Biol (2018)

A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability

Por Burridge, Paul W., Thompson, Susan, Millrod, Michal A., Weinberg, Seth, Yuan, Xuan, Peters, Ann, Mahairaki, Vasiliki, Koliatsos, Vassilis E., Tung, Leslie, Zambidis, Elias T.
Publicado em 2011

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Por Bhattacharya, Subarna, Burridge, Paul W., Kropp, Erin M., Chuppa, Sandra L., Kwok, Wai-Meng, Wu, Joseph C., Boheler, Kenneth R., Gundry, Rebekah L.
Publicado no J Vis Exp (2014)

Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency

Por Diecke, Sebastian, Lu, Jiamiao, Lee, Jaecheol, Termglinchan, Vittavat, Kooreman, Nigel G., Burridge, Paul W., Ebert, Antje D., Churko, Jared M., Sharma, Arun, Kay, Mark A., Wu, Joseph C.
Publicado no Sci Rep (2015)

Induced Pluripotent Stem Cells from Familial Alzheimer's Disease Patients Differentiate into Mature Neurons with Amyloidogenic Properties

Por Mahairaki, Vasiliki, Ryu, Jiwon, Peters, Ann, Chang, Qing, Li, Tong, Park, Tea Soon, Burridge, Paul W., Talbot, Conover C., Asnaghi, Laura, Martin, Lee J., Zambidis, Elias T., Koliatsos, Vassilis E.
Publicado no Stem Cells Dev (2014)

Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis

Por Flevaris, Panagiotis, Khan, Sadiya S., Eren, Mesut, Schuldt, Adam J. T., Shah, Sanjiv J., Lee, Daniel C., Gupta, Sweta, Shapiro, Amy D., Burridge, Paul W., Ghosh, Asish K., Vaughan, Douglas E.
Publicado no Circulation (2017)

Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation

Por Sharma, Arun, Zhang, Yuan, Buikema, Jan W., Serpooshan, Vahid, Chirikian, Orlando, Kosaric, Nina, Churko, Jared M., Dzilic, Elda, Shieh, Alice, Burridge, Paul W., Wu, Joseph C., Wu, Sean M.
Publicado no Sci Rep (2018)

Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes

Por Burridge, Paul W, Metzler, Scott A, Nakayama, Karina H, Abilez, Oscar J, Simmons, Chelsey S, Bruce, Marc A, Matsuura, Yuka, Kim, Paul, Wu, Joseph C, Butte, Manish, Huang, Ngan F, Yang, Phillip C
Publicado no Am J Transl Res (2014)

Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2

Por Yang, Xiaoyan, Park, Seong-Hoon, Chang, Hsiang-Chun, Shapiro, Jason S., Vassilopoulos, Athanassios, Sawicki, Konrad T., Chen, Chunlei, Shang, Meng, Burridge, Paul W., Epting, Conrad L., Wilsbacher, Lisa D., Jenkitkasemwong, Supak, Knutson, Mitchell, Gius, David, Ardehali, Hossein
Publicado no J Clin Invest (2017)